BACKGROUND: We developed and assessed the impact of a patient registry and electronic admission notification system relating to regional antimicrobial resistance (AMR) on regional AMR infection rates over time. We conducted an observational cohort study of all patients identified as infected or colonized with methicillin-resistant Staphylococcus aureus (MRSA) and/or vancomycin-resistant enterococci (VRE) on at least 1 occasion by any of 5 healthcare systems between 2003 and 2010. The 5 healthcare systems included 17 hospitals and associated clinics in the Indianapolis, Indiana, region. METHODS: We developed and standardized a registry of MRSA and VRE patients and created Web forms that infection preventionists (IPs) used to maintain the lists. We sent e-mail alerts to IPs whenever a patient previously infected or colonized with MRSA or VRE registered for admission to a study hospital from June 2007 through June 2010. RESULTS: Over a 3-year period, we delivered 12 748 e-mail alerts on 6270 unique patients to 24 IPs covering 17 hospitals. One in 5 (22%-23%) of all admission alerts was based on data from a healthcare system that was different from the admitting hospital; a few hospitals accounted for most of this crossover among facilities and systems. CONCLUSIONS: Regional patient registries identify an important patient cohort with relevant prior antibiotic-resistant infection data from different healthcare institutions. Regional registries can identify trends and interinstitutional movement not otherwise apparent from single institution data. Importantly, electronic alerts can notify of the need to isolate early and to institute other measures to prevent transmission.
BACKGROUND: We developed and assessed the impact of a patient registry and electronic admission notification system relating to regional antimicrobial resistance (AMR) on regional AMR infection rates over time. We conducted an observational cohort study of all patients identified as infected or colonized with methicillin-resistant Staphylococcus aureus (MRSA) and/or vancomycin-resistant enterococci (VRE) on at least 1 occasion by any of 5 healthcare systems between 2003 and 2010. The 5 healthcare systems included 17 hospitals and associated clinics in the Indianapolis, Indiana, region. METHODS: We developed and standardized a registry of MRSA and VRE patients and created Web forms that infection preventionists (IPs) used to maintain the lists. We sent e-mail alerts to IPs whenever a patient previously infected or colonized with MRSA or VRE registered for admission to a study hospital from June 2007 through June 2010. RESULTS: Over a 3-year period, we delivered 12 748 e-mail alerts on 6270 unique patients to 24 IPs covering 17 hospitals. One in 5 (22%-23%) of all admission alerts was based on data from a healthcare system that was different from the admitting hospital; a few hospitals accounted for most of this crossover among facilities and systems. CONCLUSIONS: Regional patient registries identify an important patient cohort with relevant prior antibiotic-resistant infection data from different healthcare institutions. Regional registries can identify trends and interinstitutional movement not otherwise apparent from single institution data. Importantly, electronic alerts can notify of the need to isolate early and to institute other measures to prevent transmission.
Entities:
Keywords:
MRSA; VRE; clinical decision support; health information exchange; infection control
Authors: Susan S Huang; Taliser R Avery; Yeohan Song; Kristen R Elkins; Christopher C Nguyen; Sandra K Nutter; Alaka A Nafday; Curtis J Condon; Michael T Chang; David Chrest; John Boos; Georgiy Bobashev; William Wheaton; Steven A Frank; Richard Platt; Marc Lipsitch; Robin M Bush; Stephen Eubank; Donald S Burke; Bruce Y Lee Journal: Infect Control Hosp Epidemiol Date: 2010-11 Impact factor: 3.254
Authors: J Marc Overhage; Paul R Dexter; Susan M Perkins; William H Cordell; John McGoff; Roland McGrath; Clement J McDonald Journal: Ann Emerg Med Date: 2002-01 Impact factor: 5.721
Authors: Alexander J Kallen; Yi Mu; Sandra Bulens; Arthur Reingold; Susan Petit; Ken Gershman; Susan M Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; William Schaffner; Priti R Patel; Scott K Fridkin Journal: JAMA Date: 2010-08-11 Impact factor: 56.272
Authors: Abel N Kho; Paul Dexter; Larry Lemmon; Dauna Carey; Heather Woodward-Hagg; Steve Hare; Brad Doebbeling Journal: Stud Health Technol Inform Date: 2007
Authors: Abel N Kho; Paul R Dexter; Jeff S Warvel; Anne W Belsito; Marie Commiskey; Stephen J Wilson; Siu L Hui; Clement J McDonald Journal: Int J Med Inform Date: 2007-03-29 Impact factor: 4.046
Authors: Abel N Kho; John P Cashy; Kathryn L Jackson; Adam R Pah; Satyender Goel; Jörn Boehnke; John Eric Humphries; Scott Duke Kominers; Bala N Hota; Shannon A Sims; Bradley A Malin; Dustin D French; Theresa L Walunas; David O Meltzer; Erin O Kaleba; Roderick C Jones; William L Galanter Journal: J Am Med Inform Assoc Date: 2015-06-23 Impact factor: 4.497
Authors: Kathryn L Jackson; Michael Mbagwu; Jennifer A Pacheco; Abigail S Baldridge; Daniel J Viox; James G Linneman; Sanjay K Shukla; Peggy L Peissig; Kenneth M Borthwick; David A Carrell; Suzette J Bielinski; Jacqueline C Kirby; Joshua C Denny; Frank D Mentch; Lyam M Vazquez; Laura J Rasmussen-Torvik; Abel N Kho Journal: BMC Infect Dis Date: 2016-11-17 Impact factor: 3.090
Authors: Emily Beth Devine; Annette M Totten; Paul Gorman; Karen B Eden; Steven Kassakian; Susan Woods; Monica Daeges; Miranda Pappas; Marian McDonagh; William R Hersh Journal: EGEMS (Wash DC) Date: 2017-12-07